Key References
- ROTHMAN SM: Synaptic release of excitatory amino acid neurotransmitter mediates axonal neuronal death. J. Neurosci. (1984) 4:1884–1891.
- GREENAMYRE JT, YOUNG AB: Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging (1989) 10:593–602.
- PROCTER AW, STERLING JH, STRATMANN GC, CROSS AJ, BOWEN DM: Loss of glycine-depen-dent radiological binding to the N-methyl-D-aspartate-phencyclidine receptor complex in pa-tients with Alzheimer's disease. Neurosci. Lett. (1989) 101:62–66.
- YOUNG AB, GREENAMYRE TT, HOLLINGSWORTH Z, ALBIN R, D'AmATo C, SHOULSON I, PENNEY JB: NMDA receptor losses in putamen from patients with Huntington's disease. Science (1988) 241:981–983.
- CHOI DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron (1988) 1:623–634.
- JOHNSON KM, JONES SM: Neuropharmacology of phencyclidine: basic mechanisms and ther-apeutic potential. Ann. Rev. PharmacoL ToxicoL (1990) 30:707–750.
- LEESON PD, CARLING RW, JAMES K, SMITH JD, MOORE KW, WONG EHF, BAKER R: Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel. J. Med. Chem. (1990) 33:1296–1305.
- MACDONALD JF, NOWAK LM: Mechanisms of blockade excitatory amino acid receptor chan-nels. Trends PharmacoL Sci. (1990) 11:167–172.
- OLNEY JW, LABRUYERE J, WANG G, WOZNIAK DF, PRICE MT, SESMA MA: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (1989) 244:1360–1362.
- OLNEY JW, LABRUYERE J, WANG G, WOZNIAK DF, PRICE MT, SESMA MA: NMDA antagonist neurotoxicity: mechanism and prevention. Science (1991) 254:1515–1518.
- MERCK SHARP & DoHmE Lm, US4399141.
- DAVIS et al., US3641038.
- DOBSON et al., US3716541.